GLOBAL BIRD FLU MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2023 - 2030)

Regional Analysis

• North America has established itself as the dominant region having a major share of 46.7% in the global bird flu market in 2023. The U.S. is home to several major players that manufacture vaccines and diagnostics for avian influenza. Major poultry markets in the U.S. and Canada have helped North America lead in terms of outbreak preparedness and prevention measures. Stringent food safety regulations require the widespread adoption of biosecurity systems across commercial poultry farms. Leading pharmaceutical companies in the U.S. have made major R&D investments towards developing universal avian flu vaccines. This allows North America to better tackle novel strains of avian influenza before these spread globally.
• Europe's bird flu market is expected to witness growth due to high immunization rates across the region. Several European nations have prioritized vaccine development and distribution over the past decade in response to periodic outbreaks. For example, according to the data published by European Centre for Disease Prevention and Control (ECDC), in 2018, over 200 million doses of H5N1 vaccine were administered across Europe.
• Asia Pacific has emerged as the fastest growing regional market for bird flu prevention and control. Countries like China, India, and Vietnam have tremendous poultry production and consumption. This naturally elevates the risks of avian influenza outbreaks stemming from migratory wild birds. Several tropical countries in Southeast Asia also lie along major migratory flyways from Eastern Europe and Central Asia, where outbreaks frequently occur. While still developing, the biosafety practices are rapidly expanding across small farms and live bird markets. This can potentially limit future spread within these densely populated regions. The industry presence of global vaccine manufacturers has boosted vaccination adoption in many high risk Asian nations. These players are also actively engaged in monitoring and surveillance programs with governments and veterinary organizations.